BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Lumena Pharmaceuticals 

12531 High Bluff Drive
Suite 110
San Diego  California  92130  U.S.A.
Phone: 858-461-0694 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
San Diego's Lumena Pharmaceuticals Files For $75 Million IPO To Fund Liver Drug Trials 4/4/2014 6:54:40 AM    More...
San Diego Biopharma Lumena Pharmaceuticals Secures $45 Million In Series B Financing Round 3/11/2014 6:18:55 AM    More...
Lumena Pharmaceuticals Receives Positive Opinion For Orphan Drug Designation In The European Union For LUM001 In Four Rare Liver Diseases 11/18/2013 12:05:00 PM    More...
Lumena Pharmaceuticals Receives Positive Opinion For Orphan Drug Designation In The European Union For LUM001 In Four Rare Liver Diseases 11/18/2013 11:37:27 AM    More...
Lumena Pharmaceuticals Release: Inhibition of ASBT Improves Liver Function in an Animal Model of Cholestatic Liver Disease 11/5/2013 9:10:20 AM    More...
Lumena Pharmaceuticals Receives Orphan Drug Designation From FDA and Launches Global Clinical Program 11/1/2013 9:22:26 AM    More...
Lumena Pharmaceuticals Initiates the CLARITY Phase II Study of LUM001 in Patients with Primary Biliary Cirrhosis 10/29/2013 10:44:21 AM    More...
Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children With Alagille Syndrome 9/26/2013 10:02:14 AM    More...
Lumena Pharmaceuticals Receives Orphan Drug Designation From FDA for LUM001 in Four Rare Liver Diseases 9/26/2013 10:01:03 AM    More...

//-->